{
    "title": "Japan's Daiichi Sankyo gets US FDA nod for blood cancer treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12321719/Japans-Daiichi-Sankyo-gets-US-FDA-nod-blood-cancer-therapy.html",
    "date": "2023-07-20",
    "keywords": [
        "drug",
        "treatment",
        "blood",
        "cancer",
        "growth",
        "roy",
        "sankyo",
        "type",
        "leukemia",
        "gene",
        "mutation",
        "risk",
        "relapse",
        "acquisition",
        "cost",
        "tablet",
        "mg",
        "oncology",
        "july",
        "health",
        "regulator",
        "japan",
        "path",
        "market",
        "food",
        "administration",
        "set",
        "myeloid",
        "aml",
        "review",
        "year",
        "vanflyta",
        "nod",
        "adult",
        "bone",
        "marrow",
        "company",
        "supply",
        "price",
        "novartis",
        "rydapt",
        "daiichi",
        "portfolio",
        "area",
        "start",
        "head",
        "companys",
        "business",
        "approval",
        "analyst",
        "miura",
        "flt3",
        "role",
        "lead",
        "form",
        "flt3itd",
        "survival",
        "reporting",
        "bengaluru",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}